Larada Therapeutics
- Biotech or pharma, therapeutic R&D
Larada Therapeutics, Inc. is focused on developing biotechnological products to address unmet medical needs in the ophthalmic space. Their lead product, LAR-101, is a leukotoxin protein designed to target and eliminate specific white blood cells responsible for inflammatory eye diseases associated with the ocular surface.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}